Kamiar Alaei, MD, DrPH, MPH, MS is a public service professor in the Department of Public Admiistraiton and Policy, and the founding Director of Global Institute for Health and Human Rights. He and his brother co-founded the first center for HIV/AIDS cases and drug users in Iran, which was documented by the United Nations/World Health Organization as a Best Practice model. Together with a group of experts, he also authored a major proposal to develop HIV/AIDS programs in Iran, which was awarded $15.8 million by the Global Fund.
He has traveled back and forth to the Pan American Region as a WHO/PAHO consultant to expand health and human rights training programs in the region.
Among several awards Drs. Arash and Kamiar Alaei received Heinz R. Pagels Human Rights of Scientists Award from the New York Academy of Science in 2009, the Jonathan Mann Award for Global Health and Human Rights from the Global Health Council in June 2011, the inaugural award for leadership in health and Human Rights from PAHO/WHO in 2011, and inaugural Elizabeth Taylor Award in Recognition of Efforts to Advocate for Human Rights in the field of HIV from International AIDS Society presented by Actress Sharon Stone in 2012.
Kamiar Alaei received his Medical Doctorate (MD) from Isfahan Medical University and his Master of Public Health (MPH) in epidemiology from Tehran Medical University – two of the top universities in Iran – his Master of Science in International Health from Harvard University, and his doctoral degree on Health Policy and Management from University at Albany. He is currently studying International Human Rights Law at University of Oxford.
Alaei A; Alaei K. Drug users need more choices at addiction treatment facilities. British Medical Journal (BMJ). 22 March 2013;346:f1520
Alaei A; Alaei K. Health Diplomacy, a case study: An AIDS Prevention and Treatment Initiative in the Middle East. Global Health and Diplomacy. Sept. 2012 p 40-43.
Alaei K; Alaei A. HIV/AIDS and Addiction in Iran. From a long time denial to breaking the silence. Johns Hopkins undergraduate public health research journal Epidemic Proportions. Jan.2007.
Alaei K; Alaei A; Mansoori D. Reduction of clinical Tuberculosis in HIV infected males with Isoniazid prophylaxis .Eastern Mediterranean Health Journal (EMHJ) Nov. 2002.Vol8; 6:754-757.
Alaei K; Mansoori D; Alaei A. Thrombocytopenia in HIV infected patients, Islamic Republic of Iran.Eastern Mediterranean Health Journal EMHJ Nov.2002.Vol8;6:758-764.
Alaei K.; Alaei A.; Mansoori D.; Shoshani B. Depression and anxiety in HIV-infected patients submitted to HIVIIDU Counseling & Care Center of Kermanshah province during April 2002.Journal of Psychosomatic Research, Volume 55, Number 2, August 2003, pp. 156.
Alaei K; Mansoori D; Alaei A. The response to HBV Vaccine in HIV infected patients .J of Archives of Iranian Medicine. Oct. 2003.Vol.6; No.4:20-25.
Mansoori S.D; Zadsar M; Alaei K; et al. Immunological and clinical feathers of HIV in a group of hospitalized Iranian patients .J of Archives of Iranian Medicine sciences.Autumn2003.Vol.5; No.4:10-15.
K.Alaei; D.Mansoori; A.Alaei. Study on the prevalence rate of clinical Tuberculosis in HIV infected patients in Kermanshah1997-2000.Nameh Daneshgah .J Mazandaran UMS.Sept 2002.12(35): 20-28.
Alaei K; Mansoori D; Alaei A .The efficacy of HBV Vaccine in HIV infected patients .J Babol university of medical sciences.Autumn2003.Vol.5;No.4:10-15.
Alaei K; Mansoori D; Alaei A. The efficacy of INH prophylaxis in reduction of active Tuberculosis in HIV infected cases. Tanaffos (Respiration) J. Summer 2003.Vol.2; No.2:21-27.
Mansoori D; Alaei K; Alaei A. The prevalence rate of Tuberculosis in HIV infected patients of Kermanshah province. Tanaffos (Respiration) J. Winter 2003.Vol.2; No.1:10-17.
Mansoori D; Alaei K; AlaeiA. The prevalence rate of Thrombocytopenia in HIV infected patients. Hakim Research J. Spring 2003.Vol.6; No.1:12-16